AstraZeneca Long-Term Investments 2010-2024 | AZN

AstraZeneca long-term investments for the quarter ending June 30, 2024 were $2.088B, a 82.68% increase year-over-year.

  • AstraZeneca long-term investments for 2023 were $1.905B, a 56.66% increase from 2022.
  • AstraZeneca long-term investments for 2022 were $1.216B, a 9.19% decline from 2021.
  • AstraZeneca long-term investments for 2021 were $1.339B, a 1.59% increase from 2020.

AstraZeneca Long-Term Investments 2010-2024 | AZN

  • AstraZeneca long-term investments for 2023 were $1.905B, a 56.66% increase from 2022.
  • AstraZeneca long-term investments for 2022 were $1.216B, a 9.19% decline from 2021.
  • AstraZeneca long-term investments for 2021 were $1.339B, a 1.59% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B